Found 0 matching trials
Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma PHASE2 This research study is evaluating a modified FOLFIRINOX plus bevacizumab th...
Show More Location
Yonsei University Health System, Severance Hospital
Learn More & Join Trial
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer EARLY_PHASE1 There is a growing number of patients diagnosed with gastrointestinal cance...
Show More Location
University of Arizona Cancer Center
Learn More & Join Trial
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer PHASE1 This partially randomized phase I/II trial studies the side effects and bes...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12) PHASE3 This study is a prospective, open-label, randomized phase 3 clinical trial....
Show More Location
Dong-A University Hospital
Learn More & Join Trial
Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) PHASE2 This is a prospective, randomized phase II trial. The aim of this study is ...
Show More Location
Institut Bergonié
Learn More & Join Trial
CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer PHASE2 This study is a single arm, phase II trial, of 45 patients with locally adv...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation PHASE1 A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants W...
Show More Location
Concord Cancer Centre, Concord Repatriation General Hospital, Sydney Local Health District
Learn More & Join Trial
A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer PHASE2 This study aims to assess objective response rate of modified FOLFIRINOX in...
Show More Location
Asan Medical Center
Learn More & Join Trial
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer PHASE1 This is an open label, multi-center, multi-arm, dose-escalation study of BB...
Show More Location
Mayo Clinic Arizona
Learn More & Join Trial
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC PHASE2 The purpose of this research is to study the effects and safety of alternat...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial